## CSX: CSX Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.6% below STRENGTH zone (4.0-10.0%); PEG 2.60 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($35.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. CSX Corp Price Target Raised to $30.00/Share From $27.00 by Morgan Stanley**
- Source: 富途牛牛 | 20251209T020921 | Bullish | Relevance: 97%
- Morgan Stanley has increased its price target for CSX Corp shares from $27.00 to $30.00. This adjustment reflects an updated outlook on the company's valuation.

**2. Quantbot Technologies LP Purchases 96,019 Shares of Barclays PLC $BCS**
- Source: MarketBeat | 20251207T110211 | Neutral | Relevance: 59%
-  Quantbot Technologies LP significantly increased its stake in Barclays PLC (NYSE:BCS) during the second quarter, adding 96,019 shares to hold 99,286 shares valued at approximately $1.85 million. Other institutional investors also adjusted their positions in the financial services provider. Barclays shares have shown price strength, and analysts currently rate the stock as a "Moderate Buy."

**3. Amundi Has $62 Million Position in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251209T083449 | Neutral | Relevance: 58%
-  Amundi significantly reduced its stake in Raymond James Financial, Inc. by 47.7% during the second quarter, now holding 391,970 shares valued at $62 million. Despite this reduction, several other institutional investors increased their positions in RJF. Analysts have provided mixed ratings, with a consensus "Hold" and an average target price of $177.20 for Raymond James Financial.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $30 | $27 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($2.36M) |
| Sells | 3 ($1.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (-0.4%)
- Blackrock Inc.: 7.6% (-0.8%)
- State Street Corpora: 4.6% (-2.2%)
- Bank of America Corp: 2.3% (+165.7%)
- Geode Capital Manage: 2.3% (-0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.60 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 23%, margin 20%). Analyst sentiment positive (1 raises, avg +11%). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $67.8B |
| Beta | 1.30 |
| 52W Range | $26.22 - $37.25 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.60 |
| Forward P/E | 19.1 |
| Current P/E | 22.7 |
| YoY Growth | 18.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 1.6% (minimal 5-day change). Below STRENGTH zone by 2.4pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. AM_20 at 3.8% shows strong absolute momentum above own 20MA. Outperforming sector by 3.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.61% (CS: 68) | Neutral |
| RSI_14 | 63.6 | Neutral |
| MACD Histogram | 0.22 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.025x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $36.37
- **Stop Loss:** $35.15 (3.4% risk)
- **Target:** $37.59 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 409
- **Position Value:** $14,875.33
- **Portfolio %:** 14.88%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-22 (Est: $0.44)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.42 | $0.37 | -12.9% |
| 2025Q2 | $0.42 | $0.44 | +5.4% |
| 2025Q1 | $0.37 | $0.34 | -6.9% |
| 2024Q4 | $0.42 | $0.38 | -9.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*